Wherever you go, there they are; misplaced priorities.
This is how they spend their enforcement resources in the UK.
Public Citizen has updated its 3-year old report on pharmaceutical industry fraud, and one conclusion of the report is that there has been a short-term drop in financial penalties levied against the fraudsters.
In FY 2013, over $604 million was allocated to the Health Care Fraud and Abuse Control program. Where did it go, and did it go to the right places?